Comerica Bank Amgen Inc Transaction History

Comerica Bank

$24.4 Billion
Q4 2024

A detailed history of Comerica Bank transactions in Amgen Inc stock. As of the latest transaction made, Comerica Bank holds 187,014 shares of AMGN stock, worth $57.6 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

187,014

Previous 196,994 5.07%

Holding current value

$57.6 Million

Previous $63.5 Million 23.21%

% of portfolio

0.2%

Previous 0.25%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$258.78 - $328.31 $2.58 Million - $3.28 Million	-9,980 Reduced 5.07%	187,014 $48.7 Million
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $10.4 Million - $11.4 Million	-33,662 Reduced 14.59%	196,994 $63.5 Million
Q2 2024 Aug 15, 2024	SELL	$262.75 - $319.31 $1.09 Million - $1.32 Million	-4,139 Reduced 1.76%	230,656 $72.1 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $2.74 Million - $3.31 Million	-10,186 Reduced 4.16%	234,795 $66.8 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $2.11 Million - $2.38 Million	-8,247 Reduced 3.26%	244,981 $70.6 Million
Q3 2023 Nov 21, 2023	BUY	$218.65 - $271.46 $44.5 Million - $55.3 Million	203,602 Added 410.27%	253,228 $68.1 Million
Q2 2023 Aug 22, 2023	SELL	$214.27 - $253.37 $19.9 Million - $23.5 Million	-92,887 Reduced 65.18%	49,626 $25,000
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $984,141 - $1.25 Million	-4,297 Reduced 2.93%	142,513 $0
Q3 2022 Oct 28, 2022	BUY	$224.46 - $253.15 $588,309 - $663,506	2,621 Added 1.82%	146,810 $38.4 Million
Q2 2022 Aug 02, 2022	SELL	$230.71 - $256.74 $1.86 Million - $2.07 Million	-8,053 Reduced 5.29%	144,189 $35.7 Million
Q1 2022 Apr 27, 2022	SELL	$219.27 - $242.57 $440,074 - $486,837	-2,007 Reduced 1.3%	152,242 $36.8 Million
Q4 2021 Feb 18, 2022	SELL	$198.88 - $227.6 $629,654 - $720,581	-3,166 Reduced 2.01%	154,249 $34.7 Million
Q3 2021 Nov 22, 2021	SELL	$212.27 - $248.7 $6.05 Million - $7.09 Million	-28,491 Reduced 15.33%	157,415 $33.5 Million
Q2 2021 Aug 26, 2021	SELL	$233.58 - $259.14 $2.12 Million - $2.35 Million	-9,061 Reduced 4.65%	185,906 $45.3 Million
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $673,940 - $785,368	-3,037 Reduced 1.53%	194,967 $48.5 Million
Q4 2020 Jan 28, 2021	SELL	$216.38 - $257.67 $505,247 - $601,659	-2,335 Reduced 1.17%	198,004 $45.5 Million
Q3 2020 Oct 30, 2020	BUY	$234.65 - $260.95 $563,394 - $626,540	2,401 Added 1.21%	200,339 $50.9 Million
Q2 2020 Jul 31, 2020	BUY	$197.81 - $242.74 $1.41 Million - $1.73 Million	7,107 Added 3.72%	197,938 $46.7 Million
Q1 2020 May 01, 2020	SELL	$182.24 - $241.7 $728 - $966	-4 Reduced -0.0%	190,831 $38.7 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $25,354 - $32,588	134 Added 0.07%	190,835 $46 Million
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $847,741 - $1.02 Million	-4,869 Reduced 2.49%	190,701 $36.9 Million
Q2 2019 Aug 02, 2019	SELL	$166.7 - $195.41 $2.78 Million - $3.26 Million	-16,694 Reduced 7.86%	195,570 $0
Q1 2019 May 02, 2019	BUY	$180.87 - $203.88 $175,986 - $198,375	973 Added 0.46%	212,264 $0
Q4 2018 Feb 06, 2019	SELL	$178.4 - $208.25 $998,148 - $1.17 Million	-5,595 Reduced 2.58%	211,291 $40.6 Million
Q3 2018 Nov 01, 2018	SELL	$185.29 - $208.89 $7.3 Million - $8.23 Million	-39,389 Reduced 15.37%	216,886 $42.9 Million
Q2 2018 Aug 01, 2018	SELL	$166.05 - $186.51 $1.15 Million - $1.29 Million	-6,906 Reduced 2.62%	256,275 $49.7 Million
Q1 2018 May 01, 2018	SELL	$169.43 - $198.0 $2.63 Million - $3.07 Million	-15,495 Reduced 5.56%	263,181 $45.5 Million
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $954,001 - $1.07 Million	-5,652 Reduced 1.99%	278,676 $53.1 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $47.6 Million - $54.3 Million	284,328	284,328 $49.6 Million

Others Institutions Holding AMGN

# of Institutions

3,172

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account